KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced the results from two pivotal Phase 3 trials (COUGH-1 and COUGH-2) evaluating the ...
Mirtazapine (Zipdep (45 mg)) is an antidepressant, prescribed for depression. It alters the activity of certain chemicals in the brain to maintain mental balance. The information provided on this page ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback